Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Covington
US Department of Justice
Cerilliant
Accenture
Express Scripts
UBS
Julphar
Fuji
Moodys

Generated: October 21, 2017

DrugPatentWatch Database Preview

LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% Drug Profile

« Back to Dashboard

What is the patent landscape for Lidocaine Hydrochloride 0.2% In Dextrose 5%, and when can generic versions of Lidocaine Hydrochloride 0.2% In Dextrose 5% launch?

Lidocaine Hydrochloride 0.2% In Dextrose 5% is a drug marketed by Hospira and Abbott and is included in three NDAs.

The generic ingredient in LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

Summary for Tradename: LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5%

US Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: see list4
Bulk Api Vendors: see list33
Clinical Trials: see list3,273
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% at DailyMed

Pharmacology for Tradename: LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5%

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5%
lidocaine hydrochloride
INJECTABLE;INJECTION083158-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbott
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
INJECTABLE;INJECTION018954-001Jul 9, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
INJECTABLE;INJECTION018388-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Farmers Insurance
Teva
Mallinckrodt
Covington
Cerilliant
Cipla
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot